4th Annual Breast Cancer Symposium OPENING DOORS: Lab to Clinic to Patient

Hudson, NY US
September 23, 2022 to September 25, 2022
The 4th Annual Breast Cancer Symposium is being held live in person and online via a live broadcast. The sponsors and exhibitors of the conference will be available for attendees to visit during the duration of the conference in both platforms.
Advances in our understanding of the genetic and physiologic pathways of breast cancer have led to the development of targeted systemic therapies, improved surgical procedures, and radiation techniques, and improved, disease-free, and overall survival benefits. The goal of this conference is to educate the medical and global community in a forum that will facilitate the utilization of optimal treatment strategies and foster communication that will benefit the individual patient as well as the community.

Target Audience

Medical, surgical, and radiation oncologists as well as primary care physicians, gynecologists, medical professionals and health care professionals with an interest in breast cancer are invited to attend.

Learning Objectives

After completing this activity, participants will be able to:

  • Review the recent developments in breast surgical approaches including upfront and after neoadjuvant chemotherapy;
  • Explain the rationale for reconstruction options post neoadjuvant chemotherapy and radiation therapy;
  • Discuss updates in breast cancer imaging for earlier detection;
  • Identify therapeutic advances in early and advanced hormone receptor-positive, HER2 neu overexpressing, and triple-negative breast cancer;
  • Review the advances in radiation therapy and outcomes including short-course radiation therapy and de-escalation;
  • Describe the management of HER2 positive early breast cancer in the older patient;
  • Review the treatment of early-stage inherited breast cancer;
  • Identify the new and emerging systemic treatment options for breast cancer brain metastases beyond surgery and radiotherapy;
  • Describe molecular profiling for metastatic breast cancer management;
  • Explain the mechanism of action and rationale for immunotherapy.
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
CME Coordinator Contact Email: 
Available credit: 
  • 16.50 AMA PRA Category 1 Credit™
  • 16.50 Participation
Event starts: 
09/23/2022 - 8:00am
Event ends: 
09/25/2022 - 3:40pm
Activity opens: 
Activity expires: 
Hudson Hall
327 Warren Street
Hudson, NY 12534
United States

Learners can attend this conference in person or virtually.

To learn more about the 4th Annual Breast Cancer Symposium, visit the symposium's website.
Contact myMedEd via e-mail here.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at BCS@mymededco.com.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

  Maria Theodoulou, MD
  Program Director
  Breast Cancer Medicine
  New York Oncology Hematology
  Albany, New York

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and New York Oncology Hematology, PC, and in collaboration with my myMedEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University Of Chicago Pritzker School Of Medicine designates this live activity for a maximum of 16.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professions Credit
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
REGISTRATION: Complete conference information and registration can be accessed by clicking below!
Please login or create an account to proceed.